CD8A and neoplasm: KRAS-mutant tumors exhibit elevated histone lactylation (H3K18la) in tumor-specific CD8+ T cells, while p300-catalyzed APOC2 lactylation in NSCLC induces extracellular lipolysis and Treg accumulation, driving immune checkpoint blockade (ICB) resistance (Chen et al., 2024).